Characterization of Orally Active Nonpeptide Vasopressin V<INF>2</INF> Receptor Agonist. Synthesis and Biological Evaluation of Both the (5R)- and (5S)-Enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin- 5-yl]-N-isopropylacetamide
MLA
Kondo, K., et al. “Characterization of Orally Active Nonpeptide Vasopressin V2 Receptor Agonist. Synthesis and Biological Evaluation of Both the (5R)- and (5S)-Enantioisomers of 2-[1-(2-Chloro-4-Pyrrolidin-1-Yl-Benzoyl)-2,3,4,5-Tetrahydro-1H-1-Benzazepin- 5-Yl]-N-Isopropylacetamide.” Journal of Medicinal Chemistry, vol. 45, no. 17, Aug. 2002, pp. 3805–08. EBSCOhost, https://doi.org/10.1021/jm020133q.
APA
Kondo, K., Kan, K., Tanada, Y., Bando, M., Shinohara, T., Kurimura, M., Ogawa, H., Nakamura, S., Hirano, T., Yamamura, Y., Kido, M., Mori, T., & Tominaga, M. (2002). Characterization of Orally Active Nonpeptide Vasopressin V2 Receptor Agonist. Synthesis and Biological Evaluation of Both the (5R)- and (5S)-Enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin- 5-yl]-N-isopropylacetamide. Journal of Medicinal Chemistry, 45(17), 3805–3808. https://doi.org/10.1021/jm020133q
Chicago
Kondo, K., K. Kan, Y. Tanada, M. Bando, T. Shinohara, M. Kurimura, H. Ogawa, et al. 2002. “Characterization of Orally Active Nonpeptide Vasopressin V2 Receptor Agonist. Synthesis and Biological Evaluation of Both the (5R)- and (5S)-Enantioisomers of 2-[1-(2-Chloro-4-Pyrrolidin-1-Yl-Benzoyl)-2,3,4,5-Tetrahydro-1H-1-Benzazepin- 5-Yl]-N-Isopropylacetamide.” Journal of Medicinal Chemistry 45 (17): 3805–8. doi:10.1021/jm020133q.